These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2694482)

  • 1. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
    Reisinger EC; Horstmann RD; Dietrich M
    Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
    Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
    Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
    Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
    Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
    Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
    Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
    Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
    Salako LA; Adio RA; Walker O; Sowunmi A; Stürchler D; Mittelholzer ML; Reber-Liske R; Dickschat U
    Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
    Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
    Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
    Thimasarn K; Pinichpongse S; Malikul S; Rooney W; Tansophalaks S
    Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):404-11. PubMed ID: 2075482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP; Tangri AN; Nityanand S
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
    Lell B; Lehman LG; Schmidt-Ott JR; Sturchler D; Handschin J; Kremsner PG
    Am J Trop Med Hyg; 1998 May; 58(5):619-24. PubMed ID: 9598451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
    Na Bangchang K; Karbwang J; Banmairuroi V; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):221-5. PubMed ID: 8266221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open comparison of mefloquine, mefloquine/sulfadoxine/pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children.
    Sowunmi A; Oduola AM
    Trans R Soc Trop Med Hyg; 1995; 89(3):303-5. PubMed ID: 7660443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.